Cargando…
Mapping the binding site topology of amyloid protein aggregates using multivalent ligands
A key process in the development of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases is the aggregation of proteins to produce fibrillary aggregates with a cross β-sheet structure, amyloid. The development of reagents that can bind these aggregates with high affinity...
Autores principales: | Sanna, Elena, Rodrigues, Margarida, Fagan, Steven G., Chisholm, Timothy S., Kulenkampff, Klara, Klenerman, David, Spillantini, Maria Grazia, Aigbirhio, Franklin I., Hunter, Christopher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246084/ https://www.ncbi.nlm.nih.gov/pubmed/34257890 http://dx.doi.org/10.1039/d1sc01263k |
Ejemplares similares
-
Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
por: Rofo, Fadi, et al.
Publicado: (2021) -
Discovery of High-Affinity
Amyloid Ligands Using a
Ligand-Based Virtual Screening Pipeline
por: Chisholm, Timothy S., et al.
Publicado: (2023) -
Mechanisms for the inhibition of amyloid aggregation by small ligands
por: Ramazzotti, Matteo, et al.
Publicado: (2016) -
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
por: Rofo, Fadi, et al.
Publicado: (2022) -
Ligand effects on phase separation of multivalent macromolecules
por: Ruff, Kiersten M., et al.
Publicado: (2021)